Trial Profile
Open Label Study to Assess the Pharmacokinetics of Intranasal Ketorolac Tromethamine Following Multiple Doses of Fluticasone Propionate in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Apr 2019
Price :
$35
*
At a glance
- Drugs Ketorolac (Primary) ; Fluticasone propionate
- Indications Acute pain; Migraine
- Focus Pharmacokinetics
- Sponsors American Regent; Luitpold Pharmaceuticals
- 08 Jun 2011 New trial record